Important legal notices
   
Contact   |   Search   


Find your way around the Research site


Menu above created with UDM - used by kind permission of the author

 

For Your Editorial Planning

 

GA2LEN - Global Allergy and Asthma European Network

Press conference and plenary session
within 2nd Annual Conference

Berlin, 31 March 2006

 


WHAT?
Press Conference (10:00-11:00), followed by session “Allergy throughout life - GA²LEN in action”(11:00-13:30)

WHEN?
31 March 2006 -
Press Conference (10.00-11.00), Session “Allergy throughout life – GA²LEN in action” (11.00-13.30)

WHERE?
Palais am Funkturm, Messedamm 22, 14055 Berlin, Germany

GA²LEN (Global Allergy and Asthma European Network) is a EU-funded network of excellence, bringing together epidemiological and clinical researchers who investigate allergy and asthma across the life stages. Launched as a Network of Excellence of 25 leading European teams as well as the European Academy of Allergology and Clinical Immunology (EAACI) and the European Federation of Allergy and Airways Diseases Patients´ Associations (EFA) on February 2004, a total budget of EUR 14.4 million for a five-year period has been allocated from the EU’s Sixth Research Framework Programme for GA²LEN activities. The collaboration project reflects recognition of growing concern among European citizens about rising rates of allergy and asthma.

GA²LEN started its work with the clear intention to establish a world-wide competitive network of European centres of excellence in order to enhance the quality and relevance of research in the area of allergy and to address allergy and asthma in their totality. The network focuses its research programme on developing new ways of preventing and managing allergies and asthma. In the long term, GA²LEN aims also to decrease the socioeconomic burden of allergy and asthma in Europe. Allergic diseases are estimated to cost Europe 25 billion euros annually, with most of the costs due to reduced productivity in school or at work.

The audience of the “special event” on Friday 31 March will learn about progress made in the second year of GA²LEN existence. Research issues are examined in relation to their influences within the various age groups. Special attention is given to the fact that allergic diseases and asthma often start early in life and especially in the development of immunoglobulin E antibody (IgE) mediated allergic diseases, like hay fever and asthma, it is important not only to understand genetics but also pre-natal factors that could have an importance.

For more information on the network of excellence GA2LEN, including a list of partners, please see www.ga2len.org.

GA²LEN Annual Conference
Friday, 31 March 2006

Conference programme

10:00-11:00 Press Conference

Speakers

  • Prof. Dr. med. Torsten Zuberbier, Head of Allergy Centre Charité (Dept. of Dermatology and Allergy), Head of the European Centre for Allergy Research Foundation (ECARF); Secretary General of GA²LEN
  • Prof. Dr. med Paul van Cauwenberge, Dean of University Gent, Belgium, Coordinator of GA²LEN
  • Prof. Dr. med. Peter Burney, Vice Chairman for Research of GA²LEN, Imperial College, London, UK
  • Dr. Christian Patermann, Director for biotechnology, agriculture and food research at the European Commission, Brussels, BE

11:00- 13:30 Session “Allergy throughout life – GA²LEN in action”
Chair: Paul van Cauwenberge, GA²LEN Coordinator
Co-Chairs: Jean Bousquet, GA²LEN Vice Chairperson - Ana Nieto, EC Scientific Officer

11: 00 Welcome, Paul van Cauwenberge, GA²LEN Coordinator

11:05 Pre-Natal influences, John Warner, United Kingdom

11:30 Childhood environments, Erika von Mutius, Germany

11:50 Triggers for symptoms, Marianne van Hage, Sweden

12:10 The future of the allergy epidemic and its consequences, Peter Burney, United Kingdom

12:30 Improving care for allergic patients, Inger Kull, Sweden

12:50 What patients want from a network of excellence, Marianella Salapatas, EFA (European Federation of Asthma and Airways Diseases Patients’ Associations)

13:10 EU future programmes in Allergy and Asthma, Christian Patermann, Director, European Commission

Questions and answers - Lunch

Contacts
GA²LEN Dissemination, Anne Wilmès, 327 av. Louise, B 1050 Brussels
Tel. : +32.2.640.77.80, Fax : +32.2.647.89.29, mobile: 32.475.48.89.85
E-mail: wilmes.anne@skynet.bewilmes.anne@skynet.be

GA²LEN Berlin, Stefanie Link
Tel.: +49.30.450.51.80.44, Fax : +49.30.450.51.89.38
E-mail stefanie.link@charite.de

Media contact

Michael H. Wappelhorst, Press and information officer
Information and communication Unit, Research DG, European Commission
Tel: +32.2.298 75 75, Fax: +32.2.295 82 20
E-Mail: Michael.Wappelhorst@ec.europa.eu

Spokesperson for Science and Research
Antonia Mochan, Press and Communication DG, European Commission
Tel.: +32.2.2996 9921
E-mail Antonia.Mochan@ec.europa.eu

CONFIRMATION OF ATTENDANCE, IMPORTANT

PLEASE FAX TO +32.2.647.89.29

To apply for your attendance, please send e-mail or fax enclosed form to:

Fax: +32.2.647.89.29, E-Mail: cathy.vanstappen@ga2len.net

 

CONFIRMATION OF ATTENDANCE

“Allergy throughout life – GA²LEN in action”
GA²LEN Annual Conference
Friday 31 March
Palais am Funkturm, Messedamm 22, 14055 Berlin, Germany

[ ] Yes, I would like to attend the Press Conference (10.00 am) followed by the Session (11.00-13.30) on Friday 31 March.

Name >

Media/Publication >

Press Card No. >

Address >

>

Tel., Fax >

E-Mail >


[ ] No, I am unable to attend, but would like to receive further information (press kit)

 

Press releases I What's new on the Research pages? I TOP Top